A six-figure dividend paycheck inside your Roth sounds like the perfect retirement move, until the calendar gets involved. One overlooked timing rule can quietly turn your tax-free income into a tax bill and a…
Tens of millions in stock just left the account of the man who runs Wall Street's biggest exchange operator. Before you read a warning into it, the filing's fine print points to a different…
One stock in this five-name healthcare basket costs more in annual tax than the other four combined, and the IRS treats its payout differently from the rest. Find out which one belongs in your…
A new diagnosis forces a quick sale, and the two-year rule seems to guarantee a painful tax bill. One health-based exception rewrites the math, but a single missing document or a mismatched move-in date…
CME is posting record trading volume, yet its chief executive just cut his direct stake sharply. The filing reveals what it does and does not say about why, and which two reports investors should…
Nuclear stocks are no longer moving as one. While the AI power sell-off batters a pre-revenue reactor designer, one rival barely flinches, and the gap may reveal which business models investors still trust.
Rare earth stocks can't seem to hold a policy-fueled rally, and one pre-revenue developer is taking the hardest hit. Is the real problem Washington and Beijing, or what these companies can actually deliver?
AWS just posted its fastest growth in nearly five years, yet Amazon is bleeding cash at a record pace. Can a $220 billion spending binge pay off, or will free cash flow break the…
HSBC just handed Tesla a bullish price target, yet investors sold anyway. The gap between a merger fantasy and the company's standalone worth reveals what Wall Street really fears, and why Rivian and Lucid…